RESEARCH PAPER
Gel filtration of proteins as a result of heat-treated denaturation of cancer cells homogenate
 
More details
Hide details
1
Department of Environmental Hygiene, Institute of Agricultural Medicine, Lublin, Poland
CORRESPONDING AUTHOR
Bolesław Floriańczyk   

Department of Environmental Hygiene, Institute of Agricultural Medicine, Jaczewskiego 2, 20-090 Lublin, Poland.
 
J Pre Clin Clin Res. 2007;1(2):179–181
KEYWORDS
ABSTRACT
The study covered material from patients with brain cancer (astrocytoma G-2). Cancer cells were homogenized, and heat-treated denaturation of cancer cells homogenate was performed. The solution containing heat-stable proteins was applied to a column filled with Sephadex. The results of the study showed that metallothioneins – heat-stable proteins – appear in the eluate in the same fractions as proteins obtained from a rabbit’s liver in the same experimental conditions. The presence of zinc ions was observed in the same fractions as metallothioneins, which indicates that zinc is a stable element in the structure of proteins.
 
REFERENCES (19)
1.
Boon-Huat Bay B-H, Jin R, Huang J, Tan PH: Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med 2006, 231, 1516-1521.
 
2.
Ebadi M: Metallothionein and other zinc-binding proteins in brain. Method Enzymol 1991, 205, 363-387.
 
3.
Suzuki S, Masui Y, Ohnuki M, Miyakoda G, Mori T, Nakajima K, Sato:Induction of Metallothionein synthesis by cilostazol in mice and in human cultured neuronal cell lines. Biol Pharm Bull 2007, 30, 791- 794.
 
4.
Floriańczyk B, Osuchowski J, Kaczmarczyk R, Trojanowski T, Stryjecka-Zimmer M: Influence of metallothioneins on zinc and copper distribution in brain tumours. Folia Neuropathol 2003, 41, 11-14.
 
5.
Aschner M, Cherian MG, Klaassen CD, Palmiter RD, Erickson JC, Bush A: Metallothionein in the brain – the role in physiology and pathology. Toxicol Appl Pharm 1997, 142, 229-242.
 
6.
Floriańczyk B, Osuchowski J, Kaczmarczyk R, Starosławska E, Trojanowski T: Distribution of metallothioneins in the brain neoplastic cells. Folia Neuropathol 2005, 43, 91-96.
 
7.
Floriańczyk B: Metallothioneins and its role in metal regulation, binding of reactive oxygen species, apoptosis and cell differentiation. JPCCR 2007, 1, 16 18.
 
8.
Surowiak P, Matkowski R, Materna V, Györffy B, Wojnar A, Pudełko M, Dzięgiel P, Kornafel J, Zabel M: Metallothionein: Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance. Histol Histopathol 2005, 20, 1037-1044.
 
9.
Monden N, Abe S, Sutoh I, Hishikawa Y, Kinugasa S, Nagasue N: Prognostic significance of the expression of metallothionein, glutathione- S-transferase-π, and P-glycoprotein in curatively resected gastric cancer. Oncology 1997, 54, 391-399.
 
10.
Eaton DL, Cherian MG: Determination of metallothionein in tissue by cadmium hemoglobin affinity assay. Method Enzymol 1991, 205, 83-208.
 
11.
Pinta M: Absorpcyjna spektrometria atomowa, PWN, Warsaw 1977.
 
12.
Bremner I: Interaction between metallothionein and trace elements. Progr Food Nutr Sci 1987, 11, 1-37.
 
13.
Floriańczyk B: Czynniki indukujące syntezę metalotionein. Post Hig Med Dośw 2000, 5, 687-697.
 
14.
Floriańczyk B: Gel filtration chromatography of metallothionein obtained from rabbit liver. Annales UMCS (sect. D) 2003, 48(2), 91-94.
 
15.
Floriańczyk B: Sephadex G-75 gel filtration chromatography of metallothionein and zinc chloride. Annales UMCS, 2005, 9, 79-81.
 
16.
Frassinetti S, Bronzetti G, Caltavuturo L, Cini M, Croce CD: The role of zinc in life: a review. J Environ Pathol Toxicol Oncol 2006, 25, 597-610.
 
17.
Aschner M: Methylmercury in astrocytes – What possible significance? Neurotoxicology 1996, 17, 93-106.
 
18.
Choudhuri S, Kramer KK, Berman NE, Dalton TP, Andrews GK, Klaassen CD: Constitutive expression of metallothionein. Toxicol Appl Pharm 1995, 131, 144-154.
 
19.
Floriańczyk B: Metallothionein and manganese concentration in brain tumors. JPCCR 2007, 1, 89-91.
 
eISSN:1898-7516
ISSN:1898-2395